BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17949227)

  • 21. Trichostatin A and 5 Aza-2' deoxycytidine decrease estrogen receptor mRNA stability in ER positive MCF7 cells through modulation of HuR.
    Pryzbylkowski P; Obajimi O; Keen JC
    Breast Cancer Res Treat; 2008 Sep; 111(1):15-25. PubMed ID: 17891453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterogeneity of HLA-G gene transcription and protein expression in malignant melanoma biopsies.
    Paul P; Cabestré FA; Le Gal FA; Khalil-Daher I; Le Danff C; Schmid M; Mercier S; Avril MF; Dausset J; Guillet JG; Carosella ED
    Cancer Res; 1999 Apr; 59(8):1954-60. PubMed ID: 10213506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reversible epigenetic fingerprint-mediated glutathione-S-transferase P1 gene silencing in human leukemia cell lines.
    Karius T; Schnekenburger M; Ghelfi J; Walter J; Dicato M; Diederich M
    Biochem Pharmacol; 2011 Jun; 81(11):1329-42. PubMed ID: 21453686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional up-regulation of human leukocyte antigen class I antigens expression by 5-aza-2'-deoxycytidine in cutaneous melanoma: immunotherapeutic implications.
    Fonsatti E; Nicolay HJ; Sigalotti L; Calabrò L; Pezzani L; Colizzi F; Altomonte M; Guidoboni M; Marincola FM; Maio M
    Clin Cancer Res; 2007 Jun; 13(11):3333-8. PubMed ID: 17545540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA-G: expression in human keratinocytes in vitro and in human skin in vivo.
    Ulbrecht M; Rehberger B; Strobel I; Messer G; Kind P; Degitz K; Bieber T; Weiss EH
    Eur J Immunol; 1994 Jan; 24(1):176-80. PubMed ID: 8020553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel histone deacetylase inhibitor, scriptaid, enhances expression of functional estrogen receptor alpha (ER) in ER negative human breast cancer cells in combination with 5-aza 2'-deoxycytidine.
    Keen JC; Yan L; Mack KM; Pettit C; Smith D; Sharma D; Davidson NE
    Breast Cancer Res Treat; 2003 Oct; 81(3):177-86. PubMed ID: 14620913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic changes within the promoter region of the HLA-G gene in ovarian tumors.
    Menendez L; Walker LD; Matyunina LV; Totten KA; Benigno BB; McDonald JF
    Mol Cancer; 2008 May; 7():43. PubMed ID: 18498645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential regulation of the alcohol dehydrogenase 1B (ADH1B) and ADH1C genes by DNA methylation and histone deacetylation.
    Dannenberg LO; Chen HJ; Tian H; Edenberg HJ
    Alcohol Clin Exp Res; 2006 Jun; 30(6):928-37. PubMed ID: 16737450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA-G gene activation in tumor cells involves cis-acting epigenetic changes.
    Mouillot G; Marcou C; Rousseau P; Rouas-Freiss N; Carosella ED; Moreau P
    Int J Cancer; 2005 Mar; 113(6):928-36. PubMed ID: 15514928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of demethylating agent 5-aza-2(')-deoxycytidine and histone deacetylase inhibitor FR901228 on maspin gene expression in oral cancer cell lines.
    Murakami J; Asaumi J; Maki Y; Tsujigiwa H; Kuroda M; Nagai N; Yanagi Y; Inoue T; Kawasaki S; Tanaka N; Matsubara N; Kishi K
    Oral Oncol; 2004 Jul; 40(6):597-603. PubMed ID: 15063388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sodium butyrate upregulates expression of NKG2D ligand MICA/B in HeLa and HepG2 cell lines and increases their susceptibility to NK lysis.
    Zhang C; Wang Y; Zhou Z; Zhang J; Tian Z
    Cancer Immunol Immunother; 2009 Aug; 58(8):1275-85. PubMed ID: 19139882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential in vivo and in vitro HLA-G expression in melanoma cells: potential mechanisms.
    Chang CC; Murphy SP; Ferrone S
    Hum Immunol; 2003 Nov; 64(11):1057-63. PubMed ID: 14602236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heparanase expression is associated with histone modifications in glioblastoma.
    Hong X; Nelson K; Lemke N; Kalkanis SN
    Int J Oncol; 2012 Feb; 40(2):494-500. PubMed ID: 22001963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5-Aza-2'-deoxycitydine induces demethylation and up-regulates transcription of p16INK4A gene in human gastric cancer cell lines.
    Fang JY; Yang L; Zhu HY; Chen YX; Lu J; Lu R; Cheng ZH; Xiao SD
    Chin Med J (Engl); 2004 Jan; 117(1):99-103. PubMed ID: 14733783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unique methylation pattern of oncostatin m receptor gene in cancers of colorectum and other digestive organs.
    Deng G; Kakar S; Okudiara K; Choi E; Sleisenger MH; Kim YS
    Clin Cancer Res; 2009 Mar; 15(5):1519-26. PubMed ID: 19223499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trichostatin A, sodium butyrate, and 5-aza-2'-deoxycytidine alter the expression of glucocorticoid receptor alpha and beta isoforms in Hut-78 T- and Raji B-lymphoma cell lines.
    Piotrowska H; Jagodzinski PP
    Biomed Pharmacother; 2007 Aug; 61(7):451-4. PubMed ID: 17498915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
    Mitsdoerffer M; Schreiner B; Kieseier BC; Neuhaus O; Dichgans J; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism for inactivation of the KIP family cyclin-dependent kinase inhibitor genes in gastric cancer cells.
    Shin JY; Kim HS; Park J; Park JB; Lee JY
    Cancer Res; 2000 Jan; 60(2):262-5. PubMed ID: 10667572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antineoplastic action of 5-aza-2'-deoxycytidine (Dacogen) and depsipeptide on Raji lymphoma cells.
    Shaker S; Bernstein M; Momparler RL
    Oncol Rep; 2004 Jun; 11(6):1253-6. PubMed ID: 15138563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of proteasome inhibitors on expression of HLA-G isoforms.
    Poláková K; Bandzuchová E; Bystrická M; Pancuchárová H; Russ G
    Neoplasma; 2006; 53(6):471-7. PubMed ID: 17167714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.